Cancer Treatment

Autologous Immune Enhancement Therapy (AIET) in Oncology

Cancer is still a leading cause of death in the world yet much is still not known about its mechanisms of establishment and destruction. While surgery and/or chemo- and radiotherapies have played key roles in treatment, it is clear that in many cases they do not represent a cure. Even when patients experience tumor regression, later relapse can occur. The need to address not only additional preventive measures, but also more effective and non-toxic treatment strategies are warranted. In the multipronged approach to CANCER, one very useful latest weapon would be AIET (Autologous Immune Enhancement Therapy), which is in clinical practice in Japan since 90s for more than 15 years with good effectiveness and several clinical trials and researches are reported from institutions all over the world including from the US, though there have not been any publications in this field from Malaysian Institutes or hospitals.

• Next •